LSV Asset Management Purchases 51,300 Shares of Perrigo Company plc $PRGO

LSV Asset Management lifted its position in shares of Perrigo Company plc (NYSE:PRGO) by 62.1% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 133,900 shares of the company’s stock after purchasing an additional 51,300 shares during the period. LSV Asset Management owned 0.10% of Perrigo worth $2,982,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in the company. Norges Bank acquired a new position in Perrigo in the 2nd quarter valued at $36,755,000. Perpetual Ltd boosted its position in shares of Perrigo by 64.2% in the third quarter. Perpetual Ltd now owns 3,149,878 shares of the company’s stock valued at $70,148,000 after acquiring an additional 1,231,400 shares during the period. Ion Asset Management Ltd. grew its stake in shares of Perrigo by 34.7% in the second quarter. Ion Asset Management Ltd. now owns 3,817,621 shares of the company’s stock valued at $102,007,000 after acquiring an additional 983,727 shares in the last quarter. Goldman Sachs Group Inc. increased its position in Perrigo by 126.6% during the first quarter. Goldman Sachs Group Inc. now owns 1,159,768 shares of the company’s stock worth $32,520,000 after acquiring an additional 647,982 shares during the period. Finally, State Street Corp increased its position in Perrigo by 9.5% during the second quarter. State Street Corp now owns 7,340,323 shares of the company’s stock worth $196,134,000 after acquiring an additional 637,678 shares during the period. 95.91% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

PRGO has been the topic of a number of analyst reports. Jefferies Financial Group decreased their target price on shares of Perrigo from $27.00 to $23.00 and set a “hold” rating on the stock in a research report on Monday, October 27th. JPMorgan Chase & Co. reduced their price target on Perrigo from $20.00 to $18.00 and set a “neutral” rating on the stock in a research report on Monday, December 15th. Zacks Research cut Perrigo from a “hold” rating to a “strong sell” rating in a report on Friday, November 7th. Wall Street Zen lowered Perrigo from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Finally, Argus upgraded Perrigo to a “hold” rating in a research report on Wednesday, January 14th. One research analyst has rated the stock with a Buy rating, three have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, Perrigo has a consensus rating of “Reduce” and an average price target of $20.33.

Perrigo Trading Up 1.1%

Shares of PRGO opened at $14.54 on Tuesday. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.44 and a current ratio of 2.51. Perrigo Company plc has a 52-week low of $12.17 and a 52-week high of $30.93. The firm has a market cap of $2.00 billion, a price-to-earnings ratio of -38.25, a PEG ratio of 1.31 and a beta of 0.39. The business’s fifty day moving average is $14.19 and its 200-day moving average is $18.03.

Perrigo Company Profile

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.